These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16318377)

  • 21. The fatty liver and insulin resistance.
    Yki-Järvinen H; Westerbacka J
    Curr Mol Med; 2005 May; 5(3):287-95. PubMed ID: 15892648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of PPARgamma, transcriptional cofactors, and adiponectin in the regulation of nutrient metabolism, adipogenesis and insulin action: view from the chair.
    Berger JP
    Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S3-4. PubMed ID: 15711580
    [No Abstract]   [Full Text] [Related]  

  • 23. The relationship of obesity to the metabolic syndrome.
    Lebovitz HE
    Int J Clin Pract Suppl; 2003 Mar; (134):18-27. PubMed ID: 12793594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and metabolic disease: is adipose tissue the culprit?
    Frayn KN
    Proc Nutr Soc; 2005 Feb; 64(1):7-13. PubMed ID: 15877917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adiponectin and its role in the obesity-induced insulin resistance and related complications.
    Haluzík M; Parízková J; Haluzík MM
    Physiol Res; 2004; 53(2):123-9. PubMed ID: 15046547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block.
    Musso G
    Endocrine; 2012 Oct; 42(2):237-9. PubMed ID: 22801991
    [No Abstract]   [Full Text] [Related]  

  • 27. Correlations between the expression of the insulin sensitizing hormones, adiponectin, visfatin, and omentin, and the appetite regulatory hormone, neuropeptide Y and its receptors in subcutaneous and visceral adipose tissues.
    Nway NC; Sitticharoon C; Chatree S; Maikaew P
    Obes Res Clin Pract; 2016; 10(3):256-63. PubMed ID: 26067914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between visceral adipose tissue and adiponectin, inflammatory markers and thyroid hormones in obese males with hepatosteatosis and insulin resistance.
    Ozcelik F; Yuksel C; Arslan E; Genc S; Omer B; Serdar MA
    Arch Med Res; 2013 May; 44(4):273-80. PubMed ID: 23602473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability.
    Furler SM; Gan SK; Poynten AM; Chisholm DJ; Campbell LV; Kriketos AD
    Obesity (Silver Spring); 2006 Feb; 14(2):228-34. PubMed ID: 16571847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling.
    Kaneko H; Anzai T; Nagai T; Anzai A; Takahashi T; Mano Y; Morimoto K; Maekawa Y; Itoh H; Yoshikawa T; Ogawa S; Fukuda K
    Cardiovasc Res; 2011 Aug; 91(3):546-55. PubMed ID: 21447704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
    You T; Yang R; Lyles MF; Gong D; Nicklas BJ
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research advancement of adipocytokine adiponectin].
    Xiao FY; Lu FE
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):309-13. PubMed ID: 14992011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glucose intolerance in visceral fat syndrome].
    Matsuzawa Y
    Nihon Rinsho; 2002 Jul; 60 Suppl 7():746-51. PubMed ID: 12238130
    [No Abstract]   [Full Text] [Related]  

  • 34. [Molecular basis of metabolic syndrome].
    Tamori Y; Kasuga M
    Nihon Shokakibyo Gakkai Zasshi; 2007 Apr; 104(4):483-91. PubMed ID: 17409656
    [No Abstract]   [Full Text] [Related]  

  • 35. Adiponectin, the missing link in insulin resistance and obesity.
    Gil-Campos M; Cañete RR; Gil A
    Clin Nutr; 2004 Oct; 23(5):963-74. PubMed ID: 15380884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
    Liu LF; Purushotham A; Wendel AA; Belury MA
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of fibrosis in nonalcoholic fatty liver disease.
    Hoteit MA; Anania FA
    Curr Gastroenterol Rep; 2007 Mar; 9(1):47-53. PubMed ID: 17335677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.
    Lihn AS; Bruun JM; He G; Pedersen SB; Jensen PF; Richelsen B
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):9-15. PubMed ID: 15149722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Visceral fat and digestive disease].
    Inamori M; Akiyama T; Takahashi H; Abe Y; Nakajima A
    Nihon Shokakibyo Gakkai Zasshi; 2008 Dec; 105(12):1722-7. PubMed ID: 19057157
    [No Abstract]   [Full Text] [Related]  

  • 40. [Central fat deposits contribute to atherosclerosis and insulin resistance and peripheral fat deposits protect against atherosclerosis and insulin resistance in postmenopausal women--secondary publication].
    Tanko LB; Richelsen B; Larsen PJ
    Ugeskr Laeger; 2005 Sep; 167(38):3597-601. PubMed ID: 16219191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.